Skip to content

reinforcing kidney and activating blood serial recipe, metformin, or their combination for insulin resistance in women with polycystic ovarian syndrome: a double blind randomised controlled trial

reinforcing kidney and activating blood serial recipe, metformin, or their combination for insulin resistance in women with polycystic ovarian syndrome: a double blind randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003975
Enrollment
Unknown
Registered
2020-09-23
Start date
2020-12-25
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovarian syndrome

Interventions

Sponsors

Shanghai Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 40 years; 2. Confirmed diagnosis of PCOS according to the Rotterdam 2003 criteria (2 of 3): (1) Oligo-ovulation or anovulation; (2) Clinical and/or biochemical signs of hyperandrogenism; (3) PCOs and exclusion of other aetiologies (congenital adrenal hyperplasia, androgen-secreting tumours and Cushing's syndrome); 3. Confirmed diagnosis of insulin resistance; 4. Confirmed diagnosis of ovulatorydysfunction; 5. join voluntarily and sign an informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with known severe organ dysfunction or mental illness; 2. Use of hormonal drugs or other medications including Chinese herbal prescriptions in the past 3 months; 3. Pregnancy, postabortion or postpartum within the past 6 weeks; 4. Breastfeeding within the past 6 months.

Design outcomes

Primary

MeasureTime frame
ovulation rate;

Secondary

MeasureTime frame
Follicle-stimulating hormone (FSH);Interleukin-2 receptor;Interleukin-10;Interleukin-8;Endometrial thickness;Interleukin 1 beta;Interleukin-6;Number of small follicles;triglycerides;high-density lipoprotein cholesterol (HDL-C);Ovarian volume;cholesterol;Total testosterone (T);low-density lipoprotein cholesterol (LDL-C);Luteinising hormone (LH);Tumor necrosis factor a;Fasting insulin concentrations;Fasting glucose;

Countries

China

Contacts

Public ContactNi Xiaorong

Shanghai Traditional Chinese Medicine Hospital, Shanghai, China

1120@szy.sh.cn+86 15102108837

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026